Cinacalcet: pharmacological and clinical aspects

An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism

(2011) H.H. Malluche et al.   CLINICAL NEPHROLOGY

Acute and One-Year Effects of Cinacalcet in Patients With Persistent Primary Hyperparathyroidism After Unsuccessful Parathyroidectomy

(2009) Pedro Iglesias et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Pharmacokinetics and Pharmacodynamics of Cinacalcet in Patients with Hyperparathyroidism After Renal Transplantation

(2008) A. L. Serra et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The OPTIMA Study: Assessing a New Cinacalcet (Sensipar/Mimpara) Treatment Algorithm for Secondary Hyperparathyroidism

(2008) P. Messa et al.   Clinical Journal of the American Society of Nephrology

Calcimimetics in chronic kidney disease: evidence, opportunities and challenges

(2008) Pieter Evenepoel   KIDNEY INTERNATIONAL

Cinacalcet for the treatment of primary hyperparathyroidism

(2008) Saima Sajid-Crockett et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Erratum: A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet

(2008) Alberto Falchetti et al.   Nature clinical practice. Endocrinology & metabolism

The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats

(2007) I. Lopez et al.   KIDNEY INTERNATIONAL

THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Calcium Phosphate Metabolism and Cardiovascular Disease in Patients with Chronic Kidney Disease

(2004) Geoffrey Block et al.   SEMINARS IN DIALYSIS